Cipla | CIPLA - Zahlungsmittel Und Äquivalente





Zahlungsmittel Und Äquivalente Veränderung Datum
Arca Biopharma USD 268.47M 218.95M 2026-06
aTyr Pharma USD 16.16M 6.15M 2026-06
Bio Path 13.65M 3.37M 2022-09
Brainstorm Cell Therapeutics USD 15K 14K 2026-03
Capricor Therapeutics USD 105.42M 182.42M 2026-03
Cara Therapeutics USD 19.85M 883K 2026-03
Cipla INR 10.18B 2.22B 2026-03
Dr.Reddys Laboratories INR 11.2B 4.16B 2026-06
Immunic USD 186.63M 171.15M 2026-03
Minerva Neurosciences USD 82.3M 70.02M 2025-12
Nektar Therapeutics USD 149.58M 134.46M 2026-03
Sangamo BioSciences USD 38.34M 13.16M 2025-06
Sun Pharmaceuticals INR 97.71B 15.61B 2026-03
TherapeuticsMD 523K 89K 2024-06
UPL INR 59.75B 18.23B 2026-03